Your browser doesn't support javascript.
loading
Circulating Tumor DNA Abundance and Potential Utility in De Novo Metastatic Prostate Cancer.
Vandekerkhove, Gillian; Struss, Werner J; Annala, Matti; Kallio, Heini M L; Khalaf, Daniel; Warner, Evan W; Herberts, Cameron; Ritch, Elie; Beja, Kevin; Loktionova, Yulia; Hurtado-Coll, Antonio; Fazli, Ladan; So, Alan; Black, Peter C; Nykter, Matti; Tammela, Teuvo; Chi, Kim N; Gleave, Martin E; Wyatt, Alexander W.
Afiliação
  • Vandekerkhove G; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada.
  • Struss WJ; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada.
  • Annala M; Prostate Cancer Research Center, Faculty of Medicine and Life Sciences and BioMediTech Institute, University of Tampere, Tampere, Finland.
  • Kallio HML; Prostate Cancer Research Center, Faculty of Medicine and Life Sciences and BioMediTech Institute, University of Tampere, Tampere, Finland.
  • Khalaf D; Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada.
  • Warner EW; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada.
  • Herberts C; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada.
  • Ritch E; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada.
  • Beja K; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada.
  • Loktionova Y; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada.
  • Hurtado-Coll A; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada.
  • Fazli L; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada.
  • So A; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada.
  • Black PC; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada.
  • Nykter M; Prostate Cancer Research Center, Faculty of Medicine and Life Sciences and BioMediTech Institute, University of Tampere, Tampere, Finland.
  • Tammela T; Prostate Cancer Research Center, Faculty of Medicine and Life Sciences and BioMediTech Institute, University of Tampere, Tampere, Finland.
  • Chi KN; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada; Department of Medical Oncology, British Columbia Cancer Agency, Vancouver, Canada.
  • Gleave ME; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada.
  • Wyatt AW; Department of Urologic Sciences, Vancouver Prostate Centre, University of British Columbia, Vancouver, Canada. Electronic address: awyatt@prostatecentre.com.
Eur Urol ; 75(4): 667-675, 2019 04.
Article em En | MEDLINE | ID: mdl-30638634
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Biomarcadores Tumorais / DNA Tumoral Circulante Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: Eur Urol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias da Próstata / Biomarcadores Tumorais / DNA Tumoral Circulante Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Aged / Humans / Male / Middle aged Idioma: En Revista: Eur Urol Ano de publicação: 2019 Tipo de documento: Article País de afiliação: Canadá